Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs?


  • Eli Lilly has been outperforming the S&P 500.
  • The company’s blockbuster drug Mounjaro has been approved in China, resulting in high demand and a strong earnings report.
  • The five-year target price for Eli Lilly has been raised to $1,455 based on conservative earnings projections and a multiple of 40X.
Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals.


I first wrote about Eli Lilly (NYSE:LLY) on Sept. 11, 2023, in an article titled “Eli Lilly Stock Hit New All-Time Highs: Is It Still a Buy?” At the time, the stock was trading at $595.56 per share and

Analyst’s Disclosure: I/we have a beneficial long position in the shares of LLY, NVDA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Best Stocks Now Premium gives you access to Bill Gunderson, professional money manager & analyst with 23 years of experience.

You get Bill’s daily “live” buys and sells in his four portfolios: Emerging Growth, Ultra-Growth, Premier Growth, and Dividend & Growth. These portfolios have done very well since their 1/1/2019 inception.

JOIN NOW to get daily “live” buys and sells, weekly in-depth market-timing newsletter, access to Bill’s proprietary database with daily rankings on over 5,000 securities, and a daily live radio show!

Leave a Reply

Your email address will not be published. Required fields are marked *